ischemic stroke
Conditions
Interventions
control group:conventional therapy
Sponsors
Dongzhimen Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) It meets the diagnostic criteria of cerebral infarction in western medicine and is anterior circulation infarction; (2) Meet the diagnostic criteria of TCM apoplexy - phlegm and blood stasis; (3) Onset 2 weeks to 1 month; (4) Between the ages of 40 and 80, regardless of gender; (5) Motor function rating scale FMA<=95; (6) Those who agree to participate in this clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with brain parasitic diseases, brain trauma, brain tumors, hemorrhagic transformation after cerebral infarction, epilepsy and other diseases; (2) Previous history of cerebrovascular disease, mRS score >=2 points before the onset of this disease; (3) patients with severe liver and kidney diseases or abnormal liver and kidney function examination (ALT and AS>=1.5 ULN, Cr >1 ULN); (4) Patients with other diseases that need to be treated with drugs similar to the experimental drugs; (5) Patients with heart failure, advanced tumors, severe or progressive diseases of blood or other systems; (6) Suspect or have a history of alcohol or drug abuse; (7) Pregnant or lactating women or those who have recently had family planning; (8) Allergic to this drug or to multiple drugs; (9) Patients with severe cognitive decline, complete aphasia or even disturbance of consciousness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FMA score;MRS scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| HADS score;EQ-5D score;MoCA score;Fugl-meyer sensory Function score;ADL score;SSA score;NIHSS score;Apoplexy syndrome Factor Evaluation Scale; | — |
Countries
China
Contacts
Public ContactZhou Li
Outcome results
None listed